Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Conference on Instrumentations and Biotechnologies 2012

12 Nov 2012 - 14 Nov 2012 - Shanghai Everbright International Hotel



Bookmark and Share


Mission

CIB promotes scientific communication between academics and companies with interests in biotechnologies and instrumentations.

CIB Objectives

Create a platform and an opportunity for scientists, clinicians and researchers to communicate about topics in advanced biotechnologies and instrumentations for application to clinical research.
Act as a bridge between academics and companies to understand the development of advanced biotechnologies instrumentations, and their potential for commercialization and clinical application.
Strengthen and enhance academic dialogue and information exchange between biotechnology companies, industries and manufacturers, thereby facilitating the development of collaborative projects or partnerships.

Discuss the use of new instrumentations and devices in clinical practice and feed back experience of the instrumentations and devices to the manufacturers

Focuses

1.    Cyto-pharmacology, metabolism, efficacy and survival
2.    The use of clinical proteomic technologies, tissue imaging proteomics, antibody microarray and biomarkers for diagnosis, therapy and prognosis of disease
3.    Clinical gene microarray technologies in diagnosis of disease
4.    Cellular mathematics, biophysics, bioinformatics and computational biology
5.    Functional and molecular imaging, cellular imaging, tissue imaging and in vivo imaging
6.    Flow cytometry, cellomics, metabomics, and stem cell biology
7.    Organ functional measurements
8.    Laser capture microdissection, molecular pathologies, tissue microarray, digital imaging analysis and morphometric systems
9.    Experimental magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), thermography, and ultrasound imaging technologies
10.   Tissue bioengineering technologies

Audience and participants

Scientists, clinicians, researchers and students from universities, institutes, hospitals, and companies working on medical biotechnologies and instrumentations.



Further information
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!